MaxLinear’s 55% Revenue Rebound Meets a Stock Already Near Its Highs

MaxLinear, Inc (MXL) shares are changing hands at $71.51, a level that sits in the upper portion of the stock’s two-year range of $9.31 to $99.83. This MaxLinear stock analysis looks at whether the recent recovery in the semiconductor maker’s numbers justifies a price already well above its two-year low.

What Is Happening With the Stock Price

At $71.51, MXL trades toward the top of its two-year band, well above the $9.31 low and within reach of the $99.83 high. That positioning reflects a sharp change in sentiment: after years of semiconductor-cycle weakness, the stock has climbed substantially off its trough as trailing revenue has turned sharply higher. Investors appear to be pricing in a continuation of that recovery, which raises the bar for what the fundamentals need to deliver from here.

Quality: Is This a Financially Sound Business?

The Quality picture is mixed. Gross margin of 57.5% shows MaxLinear still commands decent pricing power on what it sells, but the company is not yet translating that into bottom-line profits: operating margin is -2.4% and net profit margin is -18.2%, with earnings per share of -$1.18. Return on equity of -21.3% and return on assets of -4.9% both confirm the business is currently unprofitable on a GAAP basis. Free cash flow is only barely positive, at $14M against $569M of trailing revenue – a 0.2% FCF yield that leaves little cushion. On the more reassuring side, the balance sheet is conservatively financed, with debt-to-equity of just 0.31 and a current ratio of 1.78, though the quick ratio of 0.69 suggests a meaningful share of current assets is tied up in inventory rather than cash or receivables. This MaxLinear stock analysis finds a company still working its way back to sustained profitability rather than one already there.

Growth: Does This Company Have Real Upside?

Growth is where the story gets more interesting – and more contradictory. Trailing-twelve-month revenue growth of 55.2% points to a strong cyclical rebound, a sharp reversal from the five-year revenue CAGR of -25.3%, which reflects the deep downturn MaxLinear endured through the broader semiconductor inventory correction. Earnings growth is not measurable (N/A) given the company remains loss-making. The gap between the negative five-year trend and the positive TTM figure is the central tension in this name: the near-term numbers say recovery, the longer-term trend says the business is only now clawing back lost ground, not yet compounding from a position of strength.

Opportunity: Is Now a Good Time to Enter?

Valuation is the weakest link, reflected in an Opportunity score of just 6 out of 100. With no GAAP earnings, there is no P/E ratio to anchor a valuation view, but EV/Revenue of 10.75 and price-to-book of 13.38 are both rich multiples for a business still posting negative margins. EV/EBITDA of -272.59 is not a meaningful figure given negative EBITDA and is best ignored rather than read literally. Combined with a share price already in the upper end of its two-year range, the risk/reward for new entrants looks stretched: investors would be paying a premium multiple for a recovery that still needs to prove itself at the operating-margin line.

MaxLinear Stock Analysis: The Bottom Line

This MaxLinear stock analysis concludes with a Hold signal from the quantitative scoring model – a data-driven starting point for further research, not a personalized recommendation to transact. The bull case rests on a genuine cyclical turn: 55.2% TTM revenue growth and a 57.5% gross margin show a business with real operating leverage if the recovery holds. The bear case is just as real – the company is still unprofitable on every conventional measure, free cash flow is razor-thin, and the stock’s climb toward the top of its two-year range means much of the good news may already be reflected in the price. Investors should weigh the disconnect between the strong TTM growth number and the still-negative five-year trend before assuming the recovery is durable. As with all equities, MaxLinear carries risk of loss, and this analysis is based on Yahoo Finance data as of September 10, 2026, which may be delayed or contain errors; it is for informational purposes only, not financial advice, and readers should conduct their own due diligence or consult a licensed advisor.